0% found this document useful (0 votes)
70 views

Transparency Market Research

This document provides an overview of the molecular cytogenetics market from 2013 to 2019. Some key points: - The global molecular cytogenetics market was valued at $469.2 million in 2013 and is estimated to reach $1.97 billion by 2019, growing at a CAGR of 23.4% during that period. - Fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (aCGH) are the major technologies used in molecular cytogenetics. Cancer diagnosis is expected to be the fastest growing application segment. - North America currently accounts for the largest share of the molecular cytogenetics market, followed by Europe. However, the Asia-

Uploaded by

api-258168768
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
70 views

Transparency Market Research

This document provides an overview of the molecular cytogenetics market from 2013 to 2019. Some key points: - The global molecular cytogenetics market was valued at $469.2 million in 2013 and is estimated to reach $1.97 billion by 2019, growing at a CAGR of 23.4% during that period. - Fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (aCGH) are the major technologies used in molecular cytogenetics. Cancer diagnosis is expected to be the fastest growing application segment. - North America currently accounts for the largest share of the molecular cytogenetics market, followed by Europe. However, the Asia-

Uploaded by

api-258168768
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 13

Transparency Market

Research
Molecular Cytogenetics Market is
growing at a CAGR of 23.4% from
2013 to 2019. y !rans"arency
Market Researc#.
Single User License:
USD 4595
Multi User License:
USD 7595
Corporate User License:
USD 10595
Molecular Cytogenetics Market is growing at a CAGR of
23.4% from 2013 to 2019. y !rans"arency Market
Researc#.
Transparency Market Research
$tate !ower%
90% $tate $treet% $uite &00.
Al'any% () 1220&
*nite+ $tates
www.trans"arencymarketresearc#.com
sales,trans"arencymarketresearc#.com
96 Page Report
Publise! Date
"1#$ug#"01%
&u' (o)
Re*uest Sa+ple
Press Release
Molecular
Cytogenetics Market

Molecular Cytogenetics Market was valued at USD 469.2 million in 2013 and is estimated to reach a
market worth USD 1.97 billion in 2019 at a !"# o$ 23.4% $rom 2013 to 2019.
&rowse the $ull re'ort at htt'())www.trans'arenc*marketresearch.com)molecular+dia,nostics+
market.html
-olecular c*to,enetics is emer,in, as an indis'ensable tool in the .eld o$ research and
dia,nosis. Until the advent o$ molecular c*to,enetics techni/ues in 1900s1 chromosomal anal*sis
was mainl* based on bandin, 'atterns. !lthou,h1 the traditional bandin, techni/ues
encountered 'roblems such as low resolution and 'oor /ualit* anal*sis. 2owever1 breakthrou,h
in 3uorescence in situ h*bridi4ation 567S28 and arra*+com'arative ,enomic h*bridi4ation 5a"28
techni/ues has enhanced the dia,nosis o$ chromosomal anomalies 'articularl* in tumor and
hematolo,ical mali,nancies. 9owada*s1 c*to,enetics techni/ues are bein, considered
mandator* in dia,nosis and 'ro,nosis o$ leukemia. :he techni/ues are considered as a standard
laborator* test since the* 'rovide ,lobal screenin, o$ abnormalities. :he sco'e o$ molecular
c*to,enetics is increasin, with the risin, cancer incidences worldwide and ,rowin, 'o'ularit* o$
'ersonali4ed medicines.
:he abilit* o$ 67S2 techni/ue to stud* cells at an inter'hase sta,e o$ the cell c*cle has made the
techni/ue a breakthrou,h in molecular c*to,enetics .eld. 67S2 techni/ue is used in the research
o$ diverse a''lications such as cancer1 cardiovascular and ,enetic disorder. :he im'etus o$ 67S2
techni/ue is a direct result o$ im'roved understandin, o$ se/uence1 structure and $unction o$
human ,enome. Similarl*1 su''orted b* technolo,ical advancements in 3uorescent microsco'es
and di,ital ima,in,1 67S2 techni/ue has emer,ed as a 're$erred tool in molecular c*to,enetics.
:he techni/ue $acilitates the anal*sis o$ sub+chromosomal re,ions and the identi.cations o$ small
translocations thereb*1 routinel* used in clinical a''lications. ;win, to the techni/ues< sensitivit*
and s'eci.cit*1 67S2 is si,ni.cantl* used in number o$ c*to,enetic and 'atholo,ical laboratories.
:he advent o$ a"2 is usherin, new standards $or the anal*sis o$ ,enome. :he technolo,* has
turned out to be a ,reatest driver $or the molecular c*to,enetics market as it is overcomin, the
!rans"arency Market Researc#
2
R,P-R. D,SCR/P./-(
Molecular
Cytogenetics Market
resolution 'roblems associated with traditional bandin, techni/ues. a"2 is 'oised to witness a
si,ni.cant ,rowth in the market and is likel* to emer,e as the $astest ,rowin, technolo,*
se,ment. a"2 has 'ro'elled the c*to,enetics market $rom the microsco'es to com'uters and
thus1 $acilitated simultaneous anal*sis o$ thousands o$ discrete re,ions o$ the ,enome. Similarl*1
the techni/ue is ,ainin, 'o'ularit* as one assa* 'er$ormed on this techni/ue is com'arable to
thousands o$ 67S2 e='eriments and hence1 saves time and cost. -oreover1 the techni/ue is
e='ected to ra'idl* su''lant 67S2 techni/ue owin, to $urther technolo,ical advancements in the
techni/ue. >ikewise1 increasin, sensitivit* o$ the a"2 techni/ue is 're$erred as a 'rimar*
dia,nosis tool $ollowed b* validation with 67S2. :he techni/ue is emer,in, as a 'ower$ul tool $or
hi,h resolution anal*sis o$ sub+microsco'ic chromosomal abnormalities. a"2 is also evolvin, as
a method o$ choice $or molecular c*to,enetics b* the researchers owin, to its work 3ow
advanta,es and cost e?ectiveness.
9orth !merica accounts $or the lar,est share o$ the molecular c*to,enetics market $ollowed b*
the @uro'ean re,ion. :he markets $or these re,ions are driven b* $actors such as increased level
o$ 'ublic awareness1 risin, cancer incidences and lar,e number o$ research institutes en,a,ed in
c*to,enetics .eld. 2owever1 !sia+Aaci.c re,ion is likel* to emer,e as the $astest ,rowin, re,ion
over the anal*sis 'eriod. ancer dia,nosis is likel* to witness a si,ni.cant ,rowth and emer,e as
the $astest ,rowin, se,ment durin, anal*sis 'eriod with a !"# o$ more than 20%.
:he ,rowin, demand $or molecular c*to,enetics techni/ues in research and data inter'retation
has resulted in /uick e='ansion o$ manu$acturers< 'roduct 'ort$olio. :he manu$acturers are
$ocused on buildin, a,,ressive strate,ies $or the develo'ment o$ innovative 'roducts that would
cater research and dia,nostic sectors. :he vendors are ea,er to ta' the emer,in, re,ions and
end+users o$ this market. -aBor 'la*ers en,a,ed in develo'ment o$ innovative molecular
c*to,enetics techni/ues are !bbott laboratories1 !?*metri=1 7nc.1 !''lies S'ectral 7ma,in,1 &7
&iolo,ical 7ndustries1 >i$e :echnolo,ies or'oration1 #oche Dia,nostics1 ;=$ord "ene :echnolo,*1
7llumina1 7nc.1 amon, others.
:he molecular c*to,enetics market is se,mented as $ollows(
-olecular *to,enetics -arket1 b* :echnolo,*
67S2
a"2
-olecular *to,enetics -arket1 b* !''lication
!rans"arency Market Researc#
3
Molecular
Cytogenetics Market
"enetic Disorders
ancer
Aersonali4ed -edicine
;thers
-olecular *to,enetics -arket1 b* "eo,ra'h*
9orth !merica
@uro'e
!sia+Aaci.c
#oC
6or Sam'le #e'ort Disit ;n(
htt'())www.trans'arenc*marketresearch.com)sam'le)sam'le.'h'E3a,FSGre'HidF110I
Capter 1 Pre0ace
111 Report Description
11" Mar2et Seg+entation
11% Researc Meto!olog'
Capter " ,3ecuti4e Su++ar'
"11 Mar2et Snapsot: 5lobal Molecular C'togenetics Mar2et 6"01" 7 "0198
"1" 5lobal Molecular C'togenetics Mar2et9 b' .ecnolog'9 "01" 6USD Million8
!rans"arency Market Researc#
4
.$&L, -: C-(.,(.
Molecular
Cytogenetics Market
"1% 5lobal Molecular C'togenetics Mar2et9 b' $pplication9 "01" 6USD Million8
Capter % Mar2et -4er4ie)
%11 /ntro!uction
%1" Mar2et Dri4ers
%1"11 /ntro!uction o0 a!4ance! tecnologies
%1"1" Rising inci!ence o0 cancer cases
%1% Mar2et Restraints
%1%11 /ssues )it +e!ical rei+burse+ent
%14 Mar2et -pportunities
%1411 $!4ent o0 (e3t 5eneration Se*uencing
%141" .apping te e+erging econo+ies
%15 Porter;s :i4e :orces $nal'sis
%1511 &argaining po)er o0 bu'ers
%151" &argaining po)er o0 suppliers
%151% .reat o0 ne) entrants
%1514 .reat o0 substitutes
%1515 Co+petiti4e ri4alr'
%16 Mar2et $ttracti4eness $nal'sis
%17 Mar2et Sare $nal'sis9 b' <e' Pla'ers 6=8
!rans"arency Market Researc#
I
Molecular
Cytogenetics Market
%1711 5lobal Molecular C'togenetics Mar2et Sare $nal'sis9 b' <e' Pla'ers 6=8
%1> ,n! User $nal'sis
%1>11 5lobal Molecular C'togenetics ,n! User $nal'sis
Capter 4 Molecular C'togenetics Mar2et9 b' .ecnolog'
411 -4er4ie)
41111 5lobal Molecular C'togenetics Mar2et9 b' .ecnolog'9 "011 ? "019 6USD Million8
41" :luorescence in situ 'bri!i@ation 6:/SA8
41"11 5lobal :/SA Mar2et9 "011 ? "019 6USD Million8
41% $rra'#Co+parati4e 5eno+ic A'bri!i@ation 6aC5A8
41%11 5lobal aC5A Mar2et9 "011 ? "019 6USD Million8
Capter 5 Molecular C'togenetics Mar2et9 b' $pplications
511 -4er4ie)
51111 5lobal Molecular C'togenetics Mar2et9 b' $pplication9 "011 ? "019 6USD Million8
51" Cancer
51"1111 5lobal Cancer $pplication Mar2et9 "011 ? "019 6USD Million8
51% Personali@e! Me!icines
51%1111 5lobal Personali@e! Me!icine $pplication Mar2et9 "011 ? "019 6USD Million8
514 5enetic Disor!ers
!rans"arency Market Researc#
6
Molecular
Cytogenetics Market
5141111 5lobal 5enetic Disor!er $pplication Mar2et9 "011 ? "019 6USD Million8
515 -ters 6(eurological9 Car!io4ascular an! /n0ectious Diseases8
5151111 5lobal -ters $pplication Mar2et9 "011 ? "019 6USD Million8
Capter 6 Molecular C'togenetics Mar2et9 b' 5eograp'
611 -4er4ie)
61111 5lobal Molecular C'togenetics Mar2et9 b' 5eograp'9 "011 ? "019 6USD Million8
61" Co+parati4e $nal'sis: Molecular C'togenetics Mar2et9 b' 5eograp'9 "01" 7 "019 6Balue
=8
61% (ort $+erica
61%11 (ort $+erica Molecular C'togenetics Mar2et9 b' .ecnolog'9 "011 ? "019 6USD
Million8
61%1" (ort $+erica Molecular C'togenetics Mar2et9 b' $pplications9 "011 ? "019 6USD
Million8
614 ,urope
61411 ,urope Molecular C'togenetics Mar2et9 b' .ecnolog'9 "011 ? "019 6USD Million8
6141" ,urope Molecular C'togenetics Mar2et9 b' $pplications9 "011 ? "019 6USD Million8
615 $sia#PaciCc
61511 $sia#PaciCc Molecular C'togenetics Mar2et9 b' .ecnolog'9 "011 ? "019 6USD Million8
6151" $sia#PaciCc Molecular C'togenetics Mar2et9 b' $pplications9 "011 ? "019 6USD
Million8
616 RoD
!rans"arency Market Researc#
7
Molecular
Cytogenetics Market
61611 RoD Molecular C'togenetics Mar2et9 b' .ecnolog'9 "011 ? "019 6USD Million8
6161" RoD Molecular C'togenetics Mar2et9 b' $pplications9 "011 ? "019 6USD Million8
Capter 7 Reco++en!ations
711 /n4est+ent in e+erging econo+ies
71" Mergers an! $c*uisitions
Capter > Co+pan' ProCles
>11 $bbott Laboratories
>1111 Co+pan' -4er4ie)
>111" :inancial -4er4ie)
>111% Pro!uct Port0olio
>1114 &usiness Strategies
>1115 Recent De4elop+ents
>1" $E'+etri39 /nc1
>1"11 Co+pan' -4er4ie)
>1"1" :inancial -4er4ie)
>1"1% Pro!uct Port0olio
>1"14 &usiness Strateg'
>1"15 Recent De4elop+ents
!rans"arency Market Researc#
0
Molecular
Cytogenetics Market
>1% $gilent .ecnologies9 /nc1
>1%11 Co+pan' -4er4ie)
>1%1" :inancial -4er4ie)
>1%1% Pro!uct Port0olio
>1%14 &usiness Strategies
>1%15 Recent De4elop+ents
>14 $pplie! Spectral /+aging9 /nc1
>1411 Co+pan' -4er4ie)
>141" :inancial -4er4ie)
>141% Pro!uct Port0olio
>1414 &usiness Strateg'
>15 &/ &iological /n!ustries
>1511 Co+pan' -4er4ie)
>151" :inancial -4er4ie)
>151% Pro!uct Port0olio
>1514 &usiness Strateg'
>16 &io#Ra! Laboratories
>1611 Co+pan' o4er4ie)
>161" :inancial -4er4ie)
>161% Pro!uct Port0olio
!rans"arency Market Researc#
9
Molecular
Cytogenetics Market
>1614 &usiness Strategies
>1615 Recent De4elop+ents
>17 C'to.est /nc1
>1711 Co+pan' -4er4ie)
>171" :inancial -4er4ie)
>171% Pro!uct Port0olio
>1714 &usiness Strateg'
>1> C'togno+i39 /nc1
>1>11 Co+pan' -4er4ie)
>1>1" :inancial -4er4ie)
>1>1% Pro!uct Port0olio
>1>14 Recent De4elop+ents
>19 :1 AoE+ann#La Roce Lt!1
>1911 Co+pan' -4er4ie)
>191" :inancial -4er4ie)
>191% Pro!uct Port0olio
>1914 &usiness Strateg'
>1915 Recent De4elop+ents
>110 /llu+ina /nc1
>11011 Co+pan' -4er4ie)
!rans"arency Market Researc#
10
Molecular
Cytogenetics Market
>1101" :inancial -4er4ie)
>1101% Pro!uct Port0olio
>11014 &usiness Strategies
>11015 Recent De4elop+ents
>111 L,/C$ &/-SFS.,MS
>11111 Co+pan' -4er4ie)
>1111" :inancial -4er4ie)
>1111% Pro!uct Port0olio
>11114 &usiness Strateg'
>11115 Recent De4elop+ent
>11" Li0e .ecnologies Corporation
>11"11 Co+pan' -4er4ie)
>11"1" :inancial -4er4ie)
>11"1% Pro!uct Port0olio
>11"14 &usiness Strateg'
>11"15 Recent De4elop+ents
>11% -30or! 5ene .ecnolog'
>11%11 Co+pan' -4er4ie)
>11%1" :inancial -4er4ie)
>11%1% Pro!uct Port0olio
!rans"arency Market Researc#
11
Molecular
Cytogenetics Market
>11%14 &usiness Strateg'
>11%15 Recent De4elop+ents
>114 Per2in,l+er9 /nc1
>11411 Co+pan' -4er4ie)
>1141" :inancial -4er4ie)
>1141% Pro!uct Port0olio
>11414 &usiness Strateg'
>11415 Recent De4elop+ents
>115 Sci5ene Corporation
>11511 Co+pan' -4er4ie)
>1151" :inancial -4er4ie)
>1151% Pro!uct Port0olio
:rans'arenc* -arket #esearch is a market intelli,ence com'an* 'rovidin, ,lobal business in$ormation
re'orts and services. ;ur e=clusive blend o$ /uantitative $orecastin, and trends anal*sis 'rovides $orward+
lookin, insi,ht $or thousands o$ decision makers.
Ce are 'rivile,ed with hi,hl* e='erienced team o$ !nal*sts1 #esearchers and onsultants1 who use
'ro'rietar* data sources and various tools and techni/ues to ,ather1 and anal*4e in$ormation. ;ur
business o?erin,s re'resent the latest and the most reliable in$ormation indis'ensable $or businesses to
sustain a com'etitive ed,e.
!rans"arency Market Researc#
12
$bout Us
Molecular
Cytogenetics Market
Contact:
:rans'arenc* -arket #esearch
90 State Street1
Suite 7001
!lban*
9J + 12207
United States
:el( K1+I10+610+1030
US! + anada :oll 6ree 066+II2+34I3
@mail( salesLtrans'arenc*marketresearch.com
Cebsite( htt'())www.trans'arenc*marketresearch.com)
!rans"arency Market Researc#
13

You might also like